China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics


China Pharma Holdings, Inc. (CPHI)

Today's Latest Price: $0.54 USD

0.04 (-7.72%)

Updated Jul 10 4:10pm

Add CPHI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 115 in China

See all "A" rated Strong Buy stocks

CPHI Stock Summary

  • China Pharma Holdings Inc's market capitalization of $23,315,063 is ahead of just 9.07% of US-listed equities.
  • Price to trailing twelve month operating cash flow for CPHI is currently 85.21, higher than 96.36% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of -41.4%, China Pharma Holdings Inc's debt growth rate surpasses merely 6.68% of about US stocks.
  • Stocks that are quantitatively similar to CPHI, based on their financial statements, market capitalization, and price volatility, are BOMN, RFP, NES, EGY, and TUSK.
  • Visit CPHI's SEC page to see the company's official filings. To visit the company's web site, go to www.chinapharmaholdings.com.
CPHI Daily Price Range
CPHI 52-Week Price Range

CPHI Stock Price Chart Technical Analysis Charts


CPHI Price/Volume Stats

Current price $0.54 52-week high $1.40
Prev. close $0.58 52-week low $0.21
Day low $0.52 Volume 990,699
Day high $0.58 Avg. volume 2,944,687
50-day MA $0.52 Dividend yield N/A
200-day MA $0.42 Market Cap 23.33M

CPHI Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CPHI Latest Social Stream


Loading social stream, please wait...

View Full CPHI Social Stream

Latest CPHI News From Around the Web

Below are the latest news stories about China Pharma Holdings Inc that investors may wish to consider to help them evaluate CPHI as an investment opportunity.

China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2020.

Yahoo | May 15, 2020

China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines

China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its subsidiary, Hainan Helpson Pharmaceutical & Biotechnology Co., Ltd. ("Helpson") launched mask production lines.

Yahoo | April 15, 2020

Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it is re-issuing its previous release that was made on March 31, 2020 to incorporate certain disclosures that are required under the NYSE American Company Guide Sections 401(h) and 610(b). Included below are these additional disclosures along with the previously disclosed financial results for the fiscal year ended December 31, 2019.

Yahoo | April 14, 2020

How Much is China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Getting Paid?

In 2005 Zhilin Li was appointed CEO of China Pharma Holdings, Inc. (NYSEMKT:CPHI). This analysis aims first to...

Yahoo | April 14, 2020

Edited Transcript of CPHI earnings conference call or presentation 31-Mar-20 12:30pm GMT

Q4 2019 China Pharma Holdings Inc Earnings Call

Yahoo | April 5, 2020

Read More 'CPHI' Stories Here

CPHI Price Returns

1-mo 8.85%
3-mo N/A
6-mo 54.82%
1-year 84.11%
3-year 145.45%
5-year 86.21%
YTD 128.04%
2019 -7.86%
2018 42.78%
2017 -30.77%
2016 62.50%
2015 -46.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.2167 seconds.